AVAPRITINIB for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where AVAPRITINIB was used for Malignant melanoma.
Most Reported Side Effects for AVAPRITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 1,527 | 15.1% | 3 | 120 |
| Off label use | 1,138 | 11.3% | 49 | 101 |
| Nausea | 1,033 | 10.2% | 5 | 93 |
| Diarrhoea | 886 | 8.8% | 6 | 86 |
| Swelling face | 481 | 4.8% | 0 | 37 |
| Memory impairment | 467 | 4.6% | 6 | 48 |
| Dizziness | 458 | 4.5% | 1 | 38 |
| Vomiting | 456 | 4.5% | 2 | 63 |
| Headache | 454 | 4.5% | 2 | 44 |
| Asthenia | 433 | 4.3% | 8 | 79 |
| Platelet count decreased | 428 | 4.2% | 9 | 54 |
| Peripheral swelling | 419 | 4.1% | 4 | 46 |
| Rash | 400 | 4.0% | 0 | 30 |
| Lacrimation increased | 396 | 3.9% | 1 | 24 |
| Decreased appetite | 391 | 3.9% | 6 | 44 |
Other Indications for AVAPRITINIB
Systemic mastocytosis (3,988)
Gastrointestinal stromal tumour (3,345)
Indolent systemic mastocytosis (843)
Advanced systemic mastocytosis (594)
Haematopoietic neoplasm (417)
Product used for unknown indication (279)
Mastocytoma (244)
Malignant mast cell neoplasm (167)
Brain neoplasm malignant (122)
Acute myeloid leukaemia (104)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)